Indications of cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Neoplastic Stem Cells Breast Prostate Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells Lymph Nodes Cell Line Epithelial Cells Neoplastic Cells, Circulating

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases57

Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Neoplasms Pancreatic Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Disease Progression Carcinoma Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Colorectal Neoplasms Neoplasm Recurrence, Local Rectal Neoplasms Endometrial Neoplasms Cell Transformation, Neoplastic Esophageal Neoplasms Liver Neoplasms Adenocarcinoma Head and Neck Neoplasms Mouth Neoplasms Bone Neoplasms Neoplasms, Hormone-Dependent Neoplasms, Radiation-Induced Carcinoma, Small Cell Neoplasms, Second Primary Neovascularization, Pathologic Gastrointestinal Neoplasms Skin Neoplasms Neoplasms, Glandular and Epithelial Genital Neoplasms, Female Precancerous Conditions Thyroid Neoplasms Neoplasms, Multiple Primary Mammary Neoplasms, Experimental Postoperative Complications Pharyngeal Neoplasms Kidney Neoplasms Melanoma Disease Models, Animal Occupational Diseases Recurrence Neoplastic Syndromes, Hereditary Adenoma Carcinoma, Lobular Breast Neoplasms, Male Neoplasms, Experimental Testicular Neoplasms Carcinoma in Situ Neoplastic Cells, Circulating Carcinoma, Intraductal, Noninfiltrating

Chemicals and Drugs49

Cancer Vaccines Neoplasm Proteins Antineoplastic Agents Receptors, Estrogen Tumor Markers, Biological RNA, Messenger Receptor, erbB-2 Prostate-Specific Antigen DNA, Neoplasm RNA, Small Interfering Tumor Suppressor Protein p53 Fluorouracil Tamoxifen Cisplatin Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal Receptors, Progesterone Antigens, Neoplasm Anticarcinogenic Agents Paclitaxel Antibodies, Monoclonal Receptor, Epidermal Growth Factor MicroRNAs Tumor Suppressor Proteins Deoxycytidine Antimetabolites, Antineoplastic DNA-Binding Proteins Taxoids Antibodies, Monoclonal, Humanized Receptors, Androgen RNA, Neoplasm BRCA2 Protein Transcription Factors Carcinogens Androgens Proto-Oncogene Proteins Nuclear Proteins Estrogens BRCA1 Protein Proto-Oncogene Proteins c-akt Protein Kinase Inhibitors Androgen Antagonists Quinazolines Estrogen Receptor alpha Carcinoembryonic Antigen DNA Primers Organoplatinum Compounds Antibiotics, Antineoplastic Enzyme Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Early Detection of Cancer Retrospective Studies Follow-Up Studies Survival Analysis Survival Rate Prospective Studies Prognosis Risk Assessment Risk Registries Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Neoplasm Staging Xenograft Model Antitumor Assays Risk Factors Combined Modality Therapy Odds Ratio Disease-Free Survival Sensitivity and Specificity Neoplasm Transplantation Blotting, Western Chemotherapy, Adjuvant Questionnaires Multivariate Analysis Kaplan-Meier Estimate Clinical Trials as Topic Transplantation, Heterologous Predictive Value of Tests Mammography Oligonucleotide Array Sequence Analysis Logistic Models Tumor Burden Reproducibility of Results Molecular Targeted Therapy Polymerase Chain Reaction SEER Program Drug Screening Assays, Antitumor Incidence Patient Selection Transfection Confidence Intervals Radiotherapy Models, Biological Biopsy Neoplasm Grading Colonoscopy Drug Administration Schedule Palliative Care Tissue Array Analysis Tomography, X-Ray Computed Flow Cytometry Immunoenzyme Techniques Gene Knockdown Techniques Mastectomy Mammary Neoplasms, Experimental Cohort Studies Genetic Testing Immunotherapy Radiotherapy, Adjuvant Prostatectomy DNA Mutational Analysis Disease Models, Animal Immunohistochemistry Chi-Square Distribution Drug Delivery Systems Lymph Node Excision Feasibility Studies Neoplasms, Experimental Genetic Therapy Biopsy, Needle Positron-Emission Tomography

Psychiatry and Psychology1

Phenomena and Processes48

Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Risk Drug Resistance, Neoplasm Mutation Odds Ratio Sensitivity and Specificity DNA Methylation Cell Survival Genotype Dose-Response Relationship, Drug Cell Movement Down-Regulation Genes, BRCA1 Cell Division Polymorphism, Genetic Cell Cycle Time Factors Apoptosis Cell Proliferation Promoter Regions, Genetic Cell Growth Processes Transfection RNA Interference Up-Regulation Gene Silencing Base Sequence Germ-Line Mutation Genes, Tumor Suppressor Genes, Neoplasm Postmenopause Diet Genes, p53 Phenotype Gene Expression Genes, BRCA2 Signal Transduction Phosphorylation Alleles Drug Synergism Chi-Square Distribution Epithelial-Mesenchymal Transition Menopause Tumor Microenvironment Epigenesis, Genetic Premenopause DNA Damage Loss of Heterozygosity

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Questionnaires SEER Program Incidence Molecular Sequence Data Base Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care37

Retrospective Studies Follow-Up Studies Survival Analysis Survival Rate Prospective Studies Risk Assessment Risk Registries Treatment Outcome National Cancer Institute (U.S.)Age Factors Risk Factors Odds Ratio Disease-Free Survival Sensitivity and Specificity Questionnaires Multivariate Analysis Kaplan-Meier Estimate Clinical Trials as Topic Predictive Value of Tests Logistic Models Reproducibility of Results SEER Program Incidence Patient Selection American Cancer Society Confidence Intervals Palliative Care Cohort Studies Genetic Testing Age Distribution Confounding Factors (Epidemiology)Sex Factors Chi-Square Distribution Occupational Exposure Practice Guidelines as Topic Feasibility Studies

Geographicals5

United States Japan China Europe Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Early Detection of Cancer Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Retrospective Studies Neoplasm Metastasis Neoplasm Invasiveness Neoplasms Pancreatic Neoplasms Mice, Nude Gene Expression Regulation, Neoplastic Cancer Vaccines Follow-Up Studies Survival Analysis Survival Rate Neoplasm Proteins Prospective Studies Prognosis Uterine Cervical Neoplasms Genetic Predisposition to Disease Antineoplastic Agents Risk Assessment Risk Disease Progression Carcinoma Registries Antineoplastic Combined Chemotherapy Protocols Carcinoma, Squamous Cell Drug Resistance, Neoplasm United States Carcinoma, Non-Small-Cell Lung Treatment Outcome Urinary Bladder Neoplasms Colorectal Neoplasms National Cancer Institute (U.S.)Reverse Transcriptase Polymerase Chain Reaction Cell Line, Tumor Gene Expression Profiling Mutation Receptors, Estrogen Neoplasm Staging Age Factors Tumor Markers, Biological Xenograft Model Antitumor Assays RNA, Messenger Neoplasm Recurrence, Local Risk Factors Survivors Receptor, erbB-2 Rectal Neoplasms Combined Modality Therapy Odds Ratio Disease-Free Survival Sensitivity and Specificity Prostate-Specific Antigen Neoplasm Transplantation Blotting, Western DNA, Neoplasm Endometrial Neoplasms Cell Transformation, Neoplastic RNA, Small Interfering Chemotherapy, Adjuvant Smoking DNA Methylation Medical Oncology Esophageal Neoplasms Questionnaires Multivariate Analysis Cell Survival Tumor Suppressor Protein p53 Kaplan-Meier Estimate Fluorouracil Tamoxifen Clinical Trials as Topic Genotype Transplantation, Heterologous Liver Neoplasms Neoplastic Stem Cells Predictive Value of Tests Cisplatin Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal Receptors, Progesterone Mammography Dose-Response Relationship, Drug Breast Cell Movement Antigens, Neoplasm Down-Regulation Oligonucleotide Array Sequence Analysis Logistic Models Genes, BRCA1 Adenocarcinoma Cell Division Head and Neck Neoplasms Tumor Burden Reproducibility of Results

No FAQ available that match "indications of cancer"